| Speaking to Business Standard, Jai Hiremath, vice-chairman and managing director of Hikal Limited, said, "We have entered into a five-year contract with Crompton for manufacturing a crop protection chemical." |
| Crompton Manufacturing Company Inc (formerly Uniroyal Chemical Company Inc) is a division of Louisiana-based Crompton Corporation that is a global marketer of polymer products and processing equipment besides speciality chemicals. Crompton has its presence in more than 100 countries across the world. |
| "We have started manufacturing this product at our plants at Panoli in Gujarat and Taloja in Maharashtra, and we will start sending shipments by this month-end," he added. |
| Hikal also has manufacturing facilities in Mahad in Maharashtra and an R&D centre and API manufacturing facility in Bangalore. |
| "This apart, we are also launching two pharmaceuticals "� gabapentin, that is used for epilepsy and bupropion that is used for depression," Hiremath said. |
| "These pharmaceuticals will be marketed in the US and the European markets in the second half of 2005," he added. US-based pharma majors Pfizer and Tewa had the patent and the six-month exclusivity respectively for gabapentin. |
| Hikal will now be the third entrant for this pharmaceutical as the patent expires in April this year. |
| Hikal had recently acquired a 50.1 per cent stake (for $6 million) in Denmark-based Marsing & Co A/S, a $60-million European pharmaceutical marketing and distribution company. |
| Tewa had the patent and the six-month exclusivity respectively for gabapentin. Hikal will now be the third entrant for this pharmaceutical as the patent expires in April this year. |
| Hikal had recently acquired a 50.1 per cent stake (for $6 million) in Denmark-based Marsing & Co A/S, a $60-million European pharmaceutical marketing and distribution company. |
Top Section
Explore Business Standard